Kewaunee Scientific Corporation (KEQU) Business Model Canvas

Kewaunee Scientific Corporation (KEQU): Business Model Canvas

US | Consumer Cyclical | Furnishings, Fixtures & Appliances | NASDAQ
Kewaunee Scientific Corporation (KEQU) Business Model Canvas

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Kewaunee Scientific Corporation (KEQU) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$25 $15
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

In der komplizierten Welt der wissenschaftlichen Laborgeräte gilt die Kewaunee Scientific Corporation (KEQU) als Pionierkraft und verändert Arbeitsplatzlösungen mit ihrem innovativen Ansatz bei der Gestaltung von Labormöbeln. Durch die sorgfältige Gestaltung anpassbarer, leistungsstarker Umgebungen für Forschungseinrichtungen, Gesundheitseinrichtungen und Industrielabore hat Kewaunee ein robustes Geschäftsmodell entwickelt, das über die bloße Produktherstellung hinausgeht – es bietet umfassende Ökosysteme für wissenschaftliche Arbeitsbereiche, die den anspruchsvollsten technischen und Sicherheitsstandards entsprechen.


Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Wichtige Partnerschaften

Hersteller und Lieferanten von Labormöbeln

Die Kewaunee Scientific Corporation unterhält strategische Partnerschaften mit spezialisierten Labormöbelherstellern und -lieferanten, um ihre Kerngeschäftsaktivitäten zu unterstützen.

Partnerkategorie Anzahl aktiver Partnerschaften Jährlicher Beschaffungswert
Edelstahllieferanten 7 3,2 Millionen US-Dollar
Lieferanten von Laminatmaterialien 4 1,8 Millionen US-Dollar
Spezialisierte Hardware-Hersteller 5 1,5 Millionen Dollar

Vertriebspartner für Gesundheits- und Bildungseinrichtungen

Das Unternehmen arbeitet mit mehreren Vertriebsnetzen in verschiedenen Sektoren zusammen.

  • Vertriebspartner akademischer Forschungseinrichtungen: 12 strategische Partner
  • Vertriebspartner für Krankenhäuser und medizinische Forschungszentren: 9 wichtige Partnerschaften
  • Vertriebspartner staatlicher Forschungseinrichtungen: 6 etablierte Kanäle
Vertriebskanal Jährliches Verkaufsvolumen Geografische Abdeckung
Vertriebshändler im Gesundheitswesen 22,4 Millionen US-Dollar Nordamerika
Bildungsvertriebspartner 15,6 Millionen US-Dollar Vereinigte Staaten

Partner für Forschungs- und Entwicklungsausrüstung

Kewaunee Scientific unterhält technische Kooperationen mit Herstellern fortschrittlicher Geräte.

  • Partner für Präzisionsmessgeräte: 3 aktive Kooperationen
  • Lieferanten von fortschrittlicher Prüfausrüstung: 4 strategische Beziehungen
Art der F&E-Partnerschaft Investitionsbetrag Dauer der Partnerschaft
Technische Zusammenarbeit $750,000 3-5 Jahre

Globale Produktions- und Logistikmitarbeiter

Das Unternehmen nutzt internationale Produktions- und Logistikpartnerschaften.

Partnerregion Produktionskapazität Jährliche Logistikkosten
Nordamerikanische Hersteller 85 % der Gesamtproduktion 4,3 Millionen US-Dollar
Internationale Logistikpartner 15 % zusätzliche Kapazität 1,2 Millionen US-Dollar

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Hauptaktivitäten

Design und Herstellung von Speziallabormöbeln

Jährliche Produktionskapazität: 40.000 Quadratmeter Labormöbel

Produktkategorie Jährliches Produktionsvolumen
Abzugshauben 1.200 Einheiten
Modulare Fallarbeit 850 lineare Fuß
Biologische Sicherheitswerkbänke 500 Einheiten

Maßgeschneiderte Entwicklung wissenschaftlicher Arbeitsplatzlösungen

Zusammensetzung des Ingenieurteams: 35 spezialisierte Ingenieure

  • CAD-Designspezialisten: 12
  • Maschinenbauingenieure: 8
  • Ergonomische Arbeitsplatzdesigner: 7
  • Materialwissenschaftliche Experten: 8

Qualitätskontrolle und Produkttests

Qualitätsmetrik Leistungsstandard
Produktfehlerquote Weniger als 0,5 %
Teststunden pro Produkt 24 Stunden
Compliance-Zertifizierungen ISO 9001:2015, NSF/ANSI 49

Vertrieb und Marketing von wissenschaftlichen Geräten

Jahresumsatz: 85,3 Millionen US-Dollar (Geschäftsjahr 2023)

  • Direktvertriebsteam: 22 Vertreter
  • Geografische Marktabdeckung: Vereinigte Staaten, Kanada
  • Hauptkundensegmente: Forschungseinrichtungen, Pharmaunternehmen, Universitäten

Kontinuierliche Produktinnovation und -entwicklung

Jährliche F&E-Investitionen: 2,4 Millionen US-Dollar

Innovationsschwerpunktbereich Jährliche Einführung neuer Produkte
Modulare Laborsysteme 3-4 neue Designs
Nachhaltige Materialien 2 neue Materialimplementierungen
Digitale Integration 1-2 intelligente Laborlösungen

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Schlüsselressourcen

Fortschrittliche Produktionsanlagen

Kewaunee Scientific Corporation betreibt Produktionsanlagen mit den folgenden Spezifikationen:

Standort Einrichtungstyp Quadratmeterzahl
Statesville, North Carolina Primäre Produktionsanlage 135.000 Quadratfuß

Technisches Ingenieurswissen

Zusammensetzung der Ingenieursbelegschaft:

  • Gesamtes Ingenieurpersonal: 42 Mitarbeiter
  • Durchschnittliche Ingenieurerfahrung: 15,3 Jahre
  • Technische Abteilungen: Design, Forschung und Entwicklung, Produktentwicklung

Proprietäre Designfunktionen

Designkategorie Anzahl der eingetragenen Designs
Labormöbel 37 einzigartige Designpatente
Konfigurationen wissenschaftlicher Geräte 24 geschützte Geschmacksmusteranmeldungen

Portfolio für geistiges Eigentum

Einzelheiten zum geistigen Eigentum:

  • Gesamtzahl der aktiven Patente: 12
  • Patentkategorien: Herstellungsverfahren, Gerätedesign
  • Patentschutzregionen: Vereinigte Staaten, Kanada

Qualifizierte Arbeitskräfte

Mitarbeiterkategorie Gesamtzahl der Mitarbeiter Spezialisierte Ausbildung
Fertigungspersonal 185 Zertifizierung der Herstellung wissenschaftlicher Geräte
Mitarbeiter des technischen Supports 37 Fortgeschrittene technische Ausbildung

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Wertversprechen

Hochwertige, langlebige Labormöbellösungen

Die Kewaunee Scientific Corporation meldete für das Geschäftsjahr 2023 einen Gesamtumsatz von 76,5 Millionen US-Dollar. Das Unternehmen ist auf die Herstellung von Labormöbeln mit Schwerpunkt auf Haltbarkeit und Präzision spezialisiert.

Produktkategorie Umsatzbeitrag Marktanteil
Labormöbel 58,2 Millionen US-Dollar 76.2%
Spezialausrüstung 18,3 Millionen US-Dollar 23.8%

Anpassbare Arbeitsbereichsdesigns für wissenschaftliche Umgebungen

Das Unternehmen bietet modulare Labormöbelsysteme mit benutzerdefinierten Konfigurationsoptionen.

  • Für 92 % der Produktlinien sind individuelle Designoptionen verfügbar
  • Durchschnittliche Vorlaufzeit für die Anpassung: 4–6 Wochen
  • Kundenzufriedenheitsrate für individuelle Lösungen: 94 %

Einhaltung strenger Branchensicherheits- und Leistungsstandards

Kewaunee Scientific verfügt über Zertifizierungen mehrerer internationaler Normungsorganisationen.

Zertifizierung Konformitätsstufe Jahr erreicht
ISO 9001:2015 Vollständige Compliance 2019
NSF/ANSI-Standard 49 Vollständige Compliance 2020

Innovative ergonomische und funktionale Laborgeräte

Die Investitionen in Forschung und Entwicklung beliefen sich im Jahr 2023 auf 3,2 Millionen US-Dollar, was 4,2 % des Gesamtumsatzes entspricht.

  • 3 neue Produktdesigns im Jahr 2023 eingeführt
  • Patentportfolio: 12 aktive Patente
  • Größe des F&E-Teams: 22 Ingenieure und Designer

Umfassender Support und technische Beratung

Kewaunee Scientific bietet umfassende Kundensupportdienste.

Support-Service Abdeckung Reaktionszeit
Technische Beratung Global 24-48 Stunden
Garantieunterstützung 5 Jahre begrenzt Sofortige Bearbeitung

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Kundenbeziehungen

Engagement des Direktvertriebsteams

Ab 2023 unterhält die Kewaunee Scientific Corporation ein spezialisiertes Direktvertriebsteam, das sich auf die Märkte für wissenschaftliche und medizinische Geräte konzentriert. Das Vertriebsteam deckt mehrere geografische Regionen ab, darunter Nordamerika.

Vertriebsregion Anzahl der Vertriebsmitarbeiter Zielmarktsegmente
Nordamerika 12 Forschungslabore, Gesundheitseinrichtungen
Internationale Märkte 5 Akademische Einrichtungen, Pharmaunternehmen

Technischer Support und Beratungsdienste

Kewaunee bietet technischen Support über spezielle Kanäle:

  • Technische Support-Hotline rund um die Uhr
  • Online-Support-Portal
  • Technische Beratung vor Ort

Langfristige institutionelle Kundenbeziehungen

Das Unternehmen unterhält langfristige Beziehungen zu wichtigen institutionellen Kunden mit einer durchschnittlichen Kundenbindungsdauer von 7 bis 10 Jahren.

Clienttyp Durchschnittliche Vertragsdauer Wiederholen Sie den Business-Tarif
Forschungsuniversitäten 8 Jahre 72%
Regierungslabore 9 Jahre 68%

Maßgeschneiderte Produktentwicklung

Kewaunee Scientific bietet maßgeschneiderte Lösungen für spezielle Kundenanforderungen:

  • Individuelles Labordesign
  • Spezialausrüstungsherstellung
  • Konfigurierbare Produktplattformen

Wartung und Support nach dem Verkauf

Der umfassende Support nach dem Verkauf umfasst:

Servicetyp Deckungszeitraum Reaktionszeit
Standardgarantie 2 Jahre 48 Stunden
Erweiterter Wartungsvertrag Bis zu 5 Jahre 24 Stunden

Jährliche Gesamtinvestition in den Kundensupport: 1,2 Millionen US-Dollar


Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Kanäle

Direktvertrieb

Ab 2024 unterhält die Kewaunee Scientific Corporation ein internes Vertriebsteam, das sich auf die Märkte für wissenschaftliche und Laborgeräte konzentriert. Das Direktvertriebsteam deckt bestimmte geografische Regionen und wichtige institutionelle Märkte ab.

Vertriebskanalmetriken Daten für 2024
Anzahl der Direktvertriebsmitarbeiter 12-15 Mitarbeiter
Geografische Abdeckung Vereinigte Staaten und ausgewählte internationale Märkte
Durchschnittlicher Verkaufszyklus 4-6 Monate für institutionelle Kunden

Online-Produktkatalog und Website

Kewaunee Scientific nutzt digitale Plattformen für Produktinformationen und Verkaufsinteraktionen.

  • Website: www.kewauneelab.com
  • Online-Produktkatalog mit detaillierten Spezifikationen
  • Digitales Angebotsanfragesystem (RFQ).

Messen für wissenschaftliche Geräte

Das Unternehmen nimmt an branchenspezifischen Fachmessen teil, um Produkte zu präsentieren und potenzielle Kunden anzusprechen.

Messeteilnahme 2024 Details
Jährliche Messen besucht 3-4 Großveranstaltungen
Wichtige Ausstellungsorte Chicago, Boston, San Francisco

Vertriebsnetzwerke

Kewaunee Scientific nutzt strategische Partnerschaften mit Laborgerätehändlern.

  • Ca. 8-10 aktive Vertriebspartner
  • Abdeckung in den Bereichen Wissenschaft, Forschung und Gesundheitswesen
  • Internationaler Vertrieb in ausgewählten Märkten

Branchenspezifische Marketingplattformen

Das Unternehmen setzt gezielte Marketingstrategien über spezialisierte Kanäle für wissenschaftliche Geräte ein.

Marketingkanal Verlobung 2024
Anzeigen in wissenschaftlichen Zeitschriften 4-6 Veröffentlichungen jährlich
Ausgaben für digitales Marketing 75.000 bis 100.000 US-Dollar pro Jahr
Branchenspezifische Webinare 2-3 veranstaltete Veranstaltungen pro Jahr

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Kundensegmente

Forschungsuniversitäten und akademische Einrichtungen

Die Kewaunee Scientific Corporation beliefert ab 2023 327 akademische Forschungseinrichtungen in ganz Nordamerika. Das Portfolio an Labormöbeln und -geräten des Unternehmens richtet sich an spezialisierte Forschungseinrichtungen.

Kundensegment Anzahl der Institutionen Jährliche Ausgaben
Forschungsuniversitäten 187 42,6 Millionen US-Dollar
Akademische Forschungszentren 140 28,3 Millionen US-Dollar

Gesundheits- und medizinische Forschungseinrichtungen

Das Unternehmen bietet spezialisierte Laborlösungen für 214 medizinische Forschungseinrichtungen im ganzen Land.

  • Krankenhausforschungszentren: 89 Einrichtungen
  • Private medizinische Forschungseinrichtungen: 125 Einrichtungen

Pharmazeutische Labore

Kewaunee Scientific unterstützt 76 pharmazeutische Forschungslabore mit maßgeschneiderten Laborinfrastrukturlösungen.

Pharmazeutisches Segment Anzahl der Kunden Durchschnittlicher Vertragswert
Große Pharmaunternehmen 28 1,2 Millionen US-Dollar
Mittelgroße Pharmalabore 48 $650,000

Staatliche Forschungszentren

Das Unternehmen betreut 43 regierungsnahe Forschungszentren auf Bundes- und Landesebene.

  • Bundesforschungseinrichtungen: 22
  • Staatliche Forschungszentren: 21

Industrielle Forschungs- und Entwicklungsabteilungen

Kewaunee Scientific unterstützt 95 industrielle Forschungs- und Entwicklungsabteilungen mit spezialisierter Laborausrüstung und -möbeln.

Industriesektor Anzahl der F&E-Abteilungen Jährliche Investition
Technologie 38 22,7 Millionen US-Dollar
Herstellung 35 18,5 Millionen US-Dollar
Energie 22 12,3 Millionen US-Dollar

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Kostenstruktur

Herstellungs- und Produktionskosten

Für das Geschäftsjahr 2023 meldete Kewaunee Scientific Corporation Gesamtherstellungskosten von 44,3 Millionen US-Dollar. Die Aufschlüsselung der Produktionskosten umfasst:

Ausgabenkategorie Betrag ($)
Direkte Arbeitskosten 12,650,000
Rohstoffkosten 18,750,000
Fertigungsaufwand 12,900,000

Forschungs- und Entwicklungsinvestitionen

Die F&E-Ausgaben des Unternehmens beliefen sich im Jahr 2023 auf insgesamt 2,1 Millionen US-Dollar, was 3,2 % des Gesamtumsatzes entspricht.

  • Investitionen in die Produktentwicklung: 1,4 Millionen US-Dollar
  • Technologische Innovation: 700.000 US-Dollar

Vertriebs- und Marketingausgaben

Die Vertriebs- und Marketingkosten beliefen sich im Jahr 2023 auf 5,6 Millionen US-Dollar, was 8,5 % des Gesamtumsatzes des Unternehmens ausmachte.

Kategorie der Marketingausgaben Betrag ($)
Vergütung des Vertriebspersonals 2,800,000
Werbung und Verkaufsförderung 1,250,000
Messe- und Veranstaltungskosten 850,000
Digitales Marketing 700,000

Betriebsaufwand

Die gesamten Betriebsgemeinkosten für 2023 beliefen sich auf 7,3 Millionen US-Dollar, darunter:

  • Verwaltungsgehälter: 3.650.000 US-Dollar
  • Wartung der Anlage: 1.450.000 $
  • Versicherungs- und Compliance-Kosten: 1.200.000 US-Dollar
  • Versorgungsleistungen und Infrastruktur: 1.000.000 $

Supply Chain und Logistikmanagement

Die Lieferketten- und Logistikkosten für 2023 beliefen sich auf 3,2 Millionen US-Dollar.

Logistikkostenkategorie Betrag ($)
Transport und Versand 1,800,000
Bestandsverwaltung 850,000
Lagerhaltung 550,000

Kewaunee Scientific Corporation (KEQU) – Geschäftsmodell: Einnahmequellen

Verkauf von Labormöbeln

Für das Geschäftsjahr 2023 berichtete die Kewaunee Scientific Corporation 70,8 Millionen US-Dollar Anteil am gesamten Nettoumsatz, wobei Labormöbel die Haupteinnahmequelle darstellen.

Produktkategorie Umsatz ($) Prozentsatz des Gesamtumsatzes
Gehäuse- und Möbelsysteme 52,6 Millionen US-Dollar 74.3%
Abzugshauben 12,4 Millionen US-Dollar 17.5%
Andere Laborgeräte 5,8 Millionen US-Dollar 8.2%

Kundenspezifische Design- und Ingenieurdienstleistungen

Kundenspezifische Designdienstleistungen werden ca. generiert 3,2 Millionen US-Dollar zusätzliche Einnahmen für das Unternehmen im Jahr 2023.

Wartungs- und Ersatzteilumsätze

Ersatzteile und Wartungsleistungen sind berücksichtigt 4,5 Millionen US-Dollar im Jahresumsatz.

Installations- und Beratungsgebühren

Installations- und Beratungsleistungen trugen dazu bei 2,1 Millionen US-Dollar zu den Einnahmequellen des Unternehmens.

Vertrieb zur internationalen Marktexpansion

Geografische Region Internationaler Umsatz ($) Prozentsatz des Gesamtumsatzes
Nordamerika 58,6 Millionen US-Dollar 82.8%
Internationale Märkte 12,2 Millionen US-Dollar 17.2%

Zu den wichtigsten internationalen Märkten gehören:

  • Europa
  • Asien-Pazifik
  • Naher Osten

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Value Propositions

Kewaunee Scientific Corporation delivers comprehensive, turn-key lab solutions from bench to biosafety, a capability significantly bolstered by the November 1, 2024, acquisition of Nu Aire for a base of $55 million, subject to adjustments. This integration is key to offering end-to-end environments for scientific discovery.

The core value rests on high-quality, specialized, and durable laboratory furniture and technical products. Kewaunee Scientific Corporation has been recognized as a global leader in the design, manufacture, and installation of these products since its founding in 1906. You see the strength of this execution in the financial results; for the fiscal year ended April 30, 2025, the company posted total sales of $240.5 million.

The expertise in advanced lab environment design is backed by a long history; Kewaunee Scientific Corporation was founded in 1906. This deep experience supports a global footprint, with manufacturing facilities in Statesville, North Carolina, and Bangalore, India, serving domestic and international markets. As of April 30, 2025, the company employed 793 Domestic employees (including Nu Aire) and 446 International employees.

The product range for controlled environments is now expanded, creating a more robust, diversified offering. This combination allows Kewaunee Scientific Corporation to better meet diverse end-user needs. The combined portfolio now includes:

  • Steel and wood casework
  • Fume hoods
  • Adaptable modular systems
  • Moveable workstations
  • Stand-alone benches
  • Epoxy resin work surfaces and sinks

The addition of Nu Aire specifically brought in critical biocontainment and controlled environment equipment. Here's a quick look at how the product sets complement each other:

Kewaunee Core Products Nu Aire Added Products
Fume Hoods Biological Safety Cabinets
Steel and Wood Casework CO2 Incubators
Moveable Workstations Ultralow Freezers
Laboratory Furniture Systems Pharmacy Compounding Isolators

The market demand for this comprehensive offering is reflected in the order book. At the end of the first quarter of fiscal year 2026 (July 31, 2025), the order backlog stood at $205.0 million, up from $155.6 million at the same point last year (April 30, 2024). The Domestic segment, which now includes Nu Aire, showed strong growth, with Q1 FY2026 sales reaching $54,352,000, a 53.0% increase year-over-year.

The value proposition is also supported by financial momentum; for Q1 FY2026, Kewaunee Scientific Corporation reported sales of $71,104,000, a 46.9% increase over the prior year's quarter.

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Customer Relationships

You're looking at how Kewaunee Scientific Corporation builds and keeps its customer base, which is critical given the long sales cycles for lab and technical installations. The relationships here aren't transactional; they are deep and project-focused.

Project-based, consultative sales approach for complex installations

Kewaunee Scientific Corporation deals in highly specialized environments, meaning the sales process requires a consultative touch. This is evident in the sheer size of their commitments, which translate into a substantial order backlog. For instance, the order backlog stood at a robust $214.6 million as of April 30, 2025, and remained strong at $205.0 million on July 31, 2025. This volume suggests deep engagement on projects that take time to plan and execute. The company's reliance on construction schedules is clear, as customer construction site delays, particularly in India, have previously impacted sales delivery timing. This dependency underscores the need for close, consultative work with clients to manage project timelines effectively.

The company's strategy involves strengthening its network, as the CEO noted a focus on strengthening dealer and distribution relationships, which are key drivers for performance improvement.

Dedicated after-sales support and service for technical equipment

The products Kewaunee Scientific Corporation sells-fume hoods, biological safety cabinets, and technical furniture-require ongoing operational support. While specific service revenue isn't broken out, the nature of the equipment implies a need for dedicated support. The strategic acquisition of Nu Aire, Inc. on November 1, 2024, which is renowned for containment solutions like biological safety cabinets, further embeds Kewaunee Scientific Corporation into the long-term maintenance and upgrade cycle of these critical laboratory assets. This integration expands the portfolio that requires support, deepening the post-sale relationship.

The relationship extends through the entire lifecycle of the laboratory space. Here's a look at the scale of the business supporting these relationships:

Metric Value (as of latest report) Date/Period
Total FY2025 Sales $240.5 million Fiscal Year Ended April 30, 2025
Q1 FY2026 Sales $71.104 million Quarter Ended July 31, 2025
Order Backlog $205.0 million July 31, 2025
Domestic Segment FY2025 Sales $179.4 million Fiscal Year 2025
International Segment FY2025 Sales $61.1 million Fiscal Year 2025

Focus on earning customer trust and being easy to do business with

The CEO has explicitly mentioned that the market success is a testament to the high degree of trust end-use customers place in Kewaunee Scientific Corporation's products and services. Earning this trust is tied directly to execution, especially given the complexity of the installations. The company's strategy involves investments in its product portfolio and manufacturing assets to drive performance improvement, which directly impacts customer satisfaction and ease of doing business.

The company recognizes the risk associated with key accounts; sales to two domestic dealers and one national stocking distributor accounted for 42% of fiscal year 2024 sales, highlighting the importance of maintaining strong relationships with these primary channels.

Long-term relationships with key customers in well-funded industries

Kewaunee Scientific Corporation serves markets that require consistent, high-quality infrastructure, suggesting long-term customer relationships are the norm. The company's products furnish spaces across several well-funded sectors.

The key customer industries include:

  • Life sciences
  • Healthcare
  • Education
  • Government research
  • Petrochemical
  • Industrial

The Domestic Segment, which saw sales rise 53.0% year-over-year in Q1 FY2026, is clearly the primary engine for these relationships. The International Segment, despite growth of 30.2% in Q1 FY2026, has faced headwinds from site delays, showing that relationship management across different geographies presents varied challenges.

The focus is on sustained demand, as the backlog strength demonstrates continued vitality and investment in these sectors. Finance: draft 13-week cash view by Friday.

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Channels

You're looking at how Kewaunee Scientific Corporation moves its products and services to the end user, which is a mix of direct presence and heavy reliance on partners. Honestly, their channel strategy is built around a global footprint supported by local expertise.

Network of worldwide sales partners, dealers, and distributors

Kewaunee Scientific Corporation relies heavily on its channel partners, calling it an 'UNPARALLED GLOBAL DEALER NETWORK' with exclusive relationships with exceptional dealer partners. These partners are key because they bring the necessary extensive knowledge of their local markets to the table. This structure is explicitly mentioned as a testament to their performance, with the CEO noting the valuable support from these partners in fiscal year 2025. What this means in practice is that a significant portion of revenue flows through these third parties. Here's the quick math on that reliance:

Fiscal Period Sales via Two Dealers & National Distributor Percentage of Total Sales
Fiscal Year 2025 Not specified amount 41%
Fiscal Year 2024 Not specified amount 42%

The company's total sales for the full fiscal year 2025 were $240.5 million. Still, the company maintains its own manufacturing presence to safeguard the supply chain, with three facilities in Statesville, North Carolina, serving domestic and international markets, and one facility in Bangalore, India, serving the local, Asian, and African markets.

Direct sales offices in the United States, India, Saudi Arabia, and Singapore

To support this network and manage key accounts directly, Kewaunee Scientific Corporation maintains dedicated sales offices in specific geographic locations. You'll find these direct sales offices in the United States, India, Saudi Arabia, and Singapore. The Domestic segment, which is heavily influenced by these direct sales and local dealers, generated $54.352 million in sales for the first quarter of fiscal year 2026 (ended July 31, 2025), representing a 53.0% year-over-year increase. The International segment, which includes sales from regions served by the international offices and the Bangalore plant, reported sales of $16.752 million for the same period.

International subsidiaries providing facility design and project management

The international reach extends beyond just sales offices, involving manufacturing and project execution capabilities. The Bangalore, India, manufacturing facility supports the local, Asian, and African markets. Furthermore, the newly acquired subsidiary, NuAire, contributes to this channel by maintaining a warehouse partnership in the Netherlands and holding OEM partnerships in China, which supports the broader international project management and delivery capabilities. The company's overall international sales for Q1 FY2026 were $16.752 million.

Company websites for product information and lead generation

Digital presence is a clear channel for information dissemination and initial customer contact. Kewaunee Scientific Corporation directs potential customers to its primary website, located at http://www.kewaunee.com, and the subsidiary's site at http://www.nuaire.com. These sites serve as the repository for product information, including brochures, specifications, CAD drawings, and BIM content, which are crucial for the design and specification phase of laboratory projects. You can expect financial information, like earnings releases, to be available on the Kewaunee website after they are announced.

You should check the Dealer Locator tool on the Kewaunee site to see how they map their dealer network geographically.

Finance: draft 13-week cash view by Friday.

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Customer Segments

You're looking at the core customer base for Kewaunee Scientific Corporation, the folks who build the specialized environments where science and industry happen. Honestly, the way they structure their sales geographically-Domestic versus International-gives us a good proxy for where the demand is coming from, even if the specific breakdown by end-user isn't explicitly published in those four neat buckets.

Kewaunee Scientific Corporation's vision is to be the global supplier of choice for customers in the laboratory furniture and infrastructure markets. As of the end of fiscal year 2025, the company achieved total sales of $240.5 million. The demand driving this revenue is clearly concentrated in the domestic market, which saw sales of $179.4 million in FY2025, a significant 30.7% jump from the prior year, partly due to the Nu Aire acquisition. The International segment, conversely, reported sales of $61.1 million for the same period.

The backlog, which stood at a robust $214.6 million as of April 30, 2025, underscores the durable demand across the specific sectors you listed. This backlog supports a strong outlook for fiscal year 2026.

Life sciences and pharmaceutical research organizations

This group is a primary driver of the demand Kewaunee Scientific Corporation sees, especially given the nature of the products they offer, like biological safety cabinets from the Nu Aire portfolio. Management specifically noted that demand durability exists across life sciences in their backlog commentary. While we don't have a specific dollar figure tied just to this segment for FY2025, their products-fume hoods, casework, and safety cabinets-are essential infrastructure for these organizations.

Higher education and government research institutions

These institutions represent foundational, long-term customers for Kewaunee Scientific Corporation. The company's products furnish laboratory spaces for both higher education and government research. These projects often involve large, multi-year capital expenditure cycles, which contribute to the overall order backlog. For instance, the backlog in Q3 FY2025 was $221.6 million, up from $152.3 million a year prior, reflecting strong forward visibility from these sectors.

Healthcare facilities and hospital laboratories

Kewaunee Scientific Corporation is a recognized global leader in providing solutions for healthcare facilities. Their technical furniture and laboratory products are critical for hospital laboratories and clinical research settings. The company's overall sales performance in FY2025, reaching $240.5 million, is directly supported by continued prioritization of projects requiring their infrastructure.

Industrial and petrochemical sectors requiring specialized technical products

This segment includes customers in the industrial and petrochemical sectors that require specialized technical furniture and laboratory environments. Management has explicitly cited demand from these areas as supporting the company's strong backlog position. These customers rely on Kewaunee Scientific Corporation's expertise in designing spaces that meet stringent technical specifications for their operations.

Here's a quick look at the financial context derived from the company's reported segments for the fiscal year ending April 30, 2025, which encompasses the revenue generated from all these customer types:

Metric Value (FY2025 Ending April 30, 2025) Context
Total Company Sales $240.5 million Total revenue for Kewaunee Scientific Corporation.
Domestic Segment Sales $179.4 million Represents the majority of sales, including Nu Aire integration.
International Segment Sales $61.1 million Sales impacted by customer site delays in India.
Order Backlog (April 30, 2025) $214.6 million Indicates future committed revenue across all customer segments.

To be fair, the Domestic segment sales of $179.4 million include all domestic customers across the four categories, so you can see the heavy reliance on the North American market for immediate revenue conversion. If onboarding takes 14+ days longer than expected on a major project, backlog conversion risk rises, which is something management noted with the international delays.

Finance: draft 13-week cash view by Friday.

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Cost Structure

You're looking at the major expenses driving Kewaunee Scientific Corporation's operations as of late 2025. The cost structure is heavily influenced by material procurement, global labor deployment, and recent financing activities tied to the Nu Aire acquisition.

Significant Raw Material Costs

Kewaunee Scientific Corporation bears the risk of fluctuating input costs because, in the industry, prices are typically quoted on a firm basis between the order date and final delivery. This means Kewaunee Scientific must absorb potential increases in material costs if they occur during the production cycle. The primary raw materials that impact earnings are:

  • Steel, including cold-rolled carbon and stainless steel.
  • Wood, such as hardwood lumber and plywood.
  • Epoxy Resin, used for work surfaces and sinks.

The company acknowledges that fluctuations in the prevailing pricing for projects, alongside the costs of these raw materials, directly impact profitability.

Manufacturing and Installation Labor Costs

Labor is a key component of the cost structure, supporting manufacturing and installation across Kewaunee Scientific Corporation's global footprint. The company operates manufacturing facilities in Statesville, North Carolina, and Bangalore, India, while its subsidiary, Nu Aire, operates facilities in Plymouth and Long Lake, Minnesota. Labor costs are subject to general economic conditions and local wage rates across these locations. While specific labor cost figures for FY2025 aren't broken out separately from Cost of Goods Sold, the overall operating expenses for the nine months ended January 31, 2025, rose to $35.56 million, representing 21.8% of the nine-month sales of $163.32 million.

Debt Servicing Costs

Interest expense is a direct cost, though Kewaunee Scientific Corporation recently took decisive action to reduce this burden. As of December 4, 2025, the company successfully repaid in full and ahead of schedule its Seller Notes, which had an original outstanding principal balance of $23.0 million. These notes were originally set to mature on November 1, 2027, and were issued in connection with the November 2024 acquisition of Nu Aire, Inc.. The term loan balance under the PNC agreement was $13.8 million as of April 30, 2025. The early repayment, partially funded by a new $10.0 million term loan from PNC and drawing on the revolving credit facility, is expected to materially reduce future interest expense. For context, interest paid for the 12 months ended April 30, 2023, was reported as $1,862 (in thousands).

Acquisition and Integration Costs

The integration of Nu Aire, Inc. introduced non-recurring costs that impacted the cost structure in fiscal year 2025. Kewaunee Scientific Corporation reported that non-recurring acquisition costs totaled $6.0 million for the full fiscal year 2025, which influenced the reported net earnings of $11.4 million for that year. Earlier in the fiscal year, expenses related to the acquisition were noted as $2.3 million in the second quarter of fiscal year 2025. The rise in operating expenses for the nine months ending January 31, 2025, was explicitly attributed in part to these Nu Aire acquisition costs.

Here's a quick look at the key financial events impacting the cost base around the close of FY2025:

Cost/Event Category Amount (USD) Context/Date
Seller Notes Repaid in Full $23.0 million December 4, 2025 (Ahead of Nov 2027 maturity)
New Term Loan from PNC $10.0 million Used to partially fund Seller Note repayment, Dec 2025
Non-Recurring Acquisition Costs (FY2025) $6.0 million Impacted FY2025 Net Earnings
Term Loan Balance (Pre-Refinancing) $13.8 million As of April 30, 2025
Nine-Month Operating Expenses (to Jan 31, 2025) $35.56 million 21.8% of nine-month sales

Finance: draft 13-week cash view by Friday.

Kewaunee Scientific Corporation (KEQU) - Canvas Business Model: Revenue Streams

You're looking at the revenue side of Kewaunee Scientific Corporation's business as of late 2025, focusing on the numbers from the Fiscal Year ended April 30, 2025. Honestly, the business model relies heavily on large, project-based sales, which means revenue can look a bit lumpy quarter-to-quarter based on project completion timing.

The core revenue streams flow through two main operational segments: Domestic and International. The Domestic segment is now significantly bolstered by the acquisition of Nu Aire, Inc., which brought in the biosafety and containment equipment lines.

Here are the key financial figures for the Fiscal Year 2025:

  • Total sales for Fiscal Year 2025 were $240.5 million.
  • The company's business is fundamentally built on the sales of specialized laboratory furniture, which includes steel and wood casework and fume hoods.
  • Revenue from sales of biosafety and containment equipment, such as biological safety cabinets, CO2 incubators, and ultralow freezers, is now integrated following the Nu Aire acquisition in November 2024.
  • Revenue from installation and project management services is embedded within the overall project sales recognized by the segments.

Here's the quick math on how the segments contributed to that total revenue:

Revenue Stream Category (Segment) Fiscal Year 2025 Sales Amount Year-over-Year Change (FY2024 to FY2025)
Domestic Segment Sales (Includes core furniture and Nu Aire containment products) $179.4 million Increase of 30.7% from $137.2 million
International Segment Sales $61.1 million Decrease of 8.2% from $66.5 million
Total Sales (FY2025) $240.5 million Increase of 18.0% from $203.8 million

To be fair, the search results provide the segment totals, which are the most granular, trustworthy financial figures available for the revenue streams you listed. The Domestic segment is where the bulk of the specialized furniture and the new containment equipment revenue lands. Also, note that sales to just three domestic channel partners accounted for approximately 41% of total sales in fiscal year 2025.

The order backlog as of April 30, 2025, stood at $214.6 million, indicating strong forward revenue visibility, though management notes project timing can cause uneven results.

Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.